The short version
Choose Suzy when you want fast access to real, verified consumers across quant and qual in one platform, and you have the budget for an annual contract. Choose BluePill when you want to test more often than a panel-based model makes affordable, and the questions are comparative rather than exploratory.
Suzy | BluePill | |
|---|---|---|
Who answers | Real verified consumers from a proprietary opt-in panel | Simulated twins built from interviews with real category buyers |
Method | Quantitative surveys, plus live interviews, focus groups and in-home testing | Simulated response to a stimulus, quant and open-ended |
Time to result | Hours for quant; longer for live qualitative | Minutes |
Qualitative | Real one-to-one interviews, focus groups, in-home product testing | Simulated open-ended response and focus-group style questioning |
Sensory and product testing | Supported through in-home product testing | Not possible - nobody can simulate taste or texture |
Commercial model | Annual platform contract, priced on question volume | Per programme - a scoped pilot or an enterprise agreement |
Iteration | Each revision is a new fielded study | Re-run instantly against the same audience |
Best for | Ongoing access to real consumers across quant and qual | Fast comparative testing before fieldwork |
Suzy's panel is the product. If regular access to real, verified consumers is what your team is missing, that is what you are buying - and simulation is not a substitute for it.
A panel you subscribe to, or a study you commission
Suzy built a first-party panel and wrapped a full research toolkit around it, so a team can go from question to real consumer answers the same day, and move between survey, interview and in-home testing without changing vendor. For an insights function that runs continuously, that is a coherent proposition and the annual model fits it.
That model is also its constraint. Contracts are sized on question volume, which means the number of questions you ask is a budget line - and teams under-use what they have bought because every study spends a finite allowance. BluePill has no per-respondent cost and no question allowance, which is why the tests people quietly skip become viable.
The trade is that BluePill's respondents are simulated. We publish parallel human-panel correlation per study rather than asking anyone to take that on faith.
One thing simulation cannot do
Suzy supports in-home product testing, and that is a genuine capability gap rather than a positioning difference. No simulation can taste a product, feel a texture or smell a fragrance. If your question is whether people like the formulation, you need real people with the real product, and that is true of BluePill and of every synthetic platform on the market.
When Suzy is the better choice
You need real consumers on tap. A continuous programme where regular access to verified respondents is the point.
Sensory or in-home product testing. Taste, texture and smell cannot be simulated by anyone.
Live qualitative with real people. Moderated interviews and focus groups where a human is on the other side.
Tracking over time. Repeat measurement with a consistent real panel.
Evidence has to stand up externally. Substantiation and regulatory work need real respondents.
When BluePill is the better choice
And several where the opposite holds.
You do not want an annual contract. Per-programme pricing with no seats and no question allowance.
You are narrowing a wide field. Many options to a shortlist before any fieldwork spend.
You want CPG category depth. Shelf context, competitive sets and category claims language built in.
The design is still changing. Re-test each revision instantly against the same audience.
Minutes matter. Hours is fast for fielded research and still a wait when a decision is live.
AI Consumer Digital Twins
Synthetic agents built on historical behavioral data, not just LLM prompts.
Not "AI Surveys"
We don't ask AI to fill out forms; we place them in a virtual market environment.
Validated Accuracy
Results are back-tested against real world sales and high-quality human panels.
Does Suzy use real consumers?
Yes. Suzy's proposition is built on its own verified opt-in consumer panel spanning many markets, used across both quantitative surveys and live qualitative research.
How do the commercial models compare?
Suzy is an annual platform contract sized on question volume, so the number of questions you ask is a budget line. BluePill is bought per programme with no per-respondent cost and no question allowance. Published third-party figures for Suzy contracts vary too widely to state as fact, so confirm pricing with them directly.
Can BluePill do in-home product testing?
No, and neither can any other synthetic platform. Nobody can simulate taste, texture or smell. If your question is whether people like the formulation, you need real people with the real product, and Suzy supports that directly.
Is BluePill faster than Suzy?
Yes. Suzy returns quantitative results in hours and live qualitative takes longer, because both field with real people. BluePill returns in minutes against an audience that already exists.
Do I still need a consumer panel if I use BluePill?
For sensory work, substantiation and anything that has to stand up externally, yes. What changes is how much panel work you commission, because the early comparative rounds no longer need to consume it.
How we made this comparison
Everything on this page about Suzy is drawn from Suzy's own public materials, with each claim linked to its source. We have deliberately avoided quoting a specific contract price, because published third-party figures vary too widely to state as fact. This page carries a review date and we check it quarterly. If you work at Suzy and think we have described something incorrectly, get in touch and we will fix it.
Last reviewed: